Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol + oliceridine vs fentanyl for laryngeal mask general anesthesia in fibrobronchoscopy
ChiCTR2400088652Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol, oliceridine and fentanyl in None, airway hyperresponsiveness (AHR) and procedural pain (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Tracheal response rate during bronchoscopy examination and Respiratory depression rate during bronchoscopy. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
ciprofololiceridinefentanyl
03
Conditions
airway hyperresponsiveness (AHR)procedural pain
Beyond the preview
Go deeper on ChiCTR2400088652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088652.